Literature DB >> 28368515

A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC).

W M Tai, W P Yong, C Lim, L S Low, C K Tham, T S Koh, Q S Ng, W W Wang, L Z Wang, S Hartono, C H Thng, H Huynh, K T Lim, H C Toh, B C Goh, S P Choo.   

Abstract

Entities:  

Year:  2018        PMID： 28368515     DOI： 10.1093/annonc/mdx060

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  1 in total

Review 1.  Role of autophagy in tumorigenesis, metastasis, targeted therapy and drug resistance of hepatocellular carcinoma.

Authors:  Fang Huang; Bing-Rong Wang; Yi-Gang Wang
Journal:  World J Gastroenterol       Date:  2018-11-07       Impact factor: 5.742
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.